SARS-CoV2 (COVID-19) Pandemic Control and Prevention

Cover
Half Title
Title Page
Copyright Page
Dedication
Table of Contents
Preface
Acknowledgements
Scientific Uncertainties
List of Figures
List of Tables
Explanation of Sections
1 Immuno-Epidemiologic Perspective in Pathogenic Microbes: Immune System Response and Integration
2 Immuno-Epidemiologic Perspective in Pathogenic Microbes: Epidemiologic Principles and Concepts
3 SARS-CoV2 (COVID-19): Pandemic and Public Health Emergency Response
4 SARS-CoV2 Mutation: Immuno-Epidemiologic and Socio-Epidemiologic Response
5 COVID-19 Pandemic: Epidemic Curve Down-Drifting and Case Fatality Mitigation
6 Pregnancy Risk in SARS-CoV2 Transmission and COVID-19 Fetal Survivability: Immuno-Epidemiologic Perspective
7 SARS-CoV2 (COVID-19) Risk Precipitation and Disproportionate Mortality in African American (AA)/Black Communities
8 Social Injustice and Systemic Racism: Obstacles to COVID-19 Pandemic Global Health Equity Transformation
9 SARS-CoV2 \"Re-Emergence\" as COVID-19 (2): Translational Public Health and Immuno-Epidemiologic Response
10 SARS-CoV2 (COVID-19) Viral Dynamics Control
11 Immune System Senescence in SARS-CoV2 Transmission and COVID-19 Clinical Manifestations, Severity and Complications
12 SARS-CoV2 Exponential Spread and COVID-19 Hospitalization, Case Fatality and Mortality: US Pandemic Mitigation and Stabilization Measures Regression
13 SARS-CoV2 (COVID-19) Synergistic Spread: Conjoint Effect of Personal Responsibility, Control/Preventive Measures and Vaccine Effectiveness
14 SARS-CoV2 Vaccine Versus Vaccination: Immunologic Durability and Community Disproportionate Benefit in the United States & Globally
15 \"COVIDMAS\" and SARS-CoV2 (COVID-19) Pandemic Attenuation: Emerging New Strain (Antigenic Subtypes) and Subpopulations Obstacles to Vaccination
16 SARS-CoV2 (COVID-19) Novel Variants (DELTA), Vaccine Cross-Effectiveness and Durability
17 SARS-CoV2 (COVID-19) Disproportionate Burden: Hypertension and Mental Health Among US Racial/Ethnic Minorities – Blacks/African Americans (AA)
18 SARS-CoV2 Delta Variant (B.1.617.2) Transmissibility, Subpopulations Case-positivity, Case Fatality and Mortality
19 Natural Disaster (Hurricane) as Health-related Event in SARS-CoV2 Delta Variant Exponential Transmissibility and Mortality
20 SARS-CoV2 (COVID-19) Vaccine Effectiveness and Durability in Immunogenic-Related Comorbidities (Multiple Myeloma)
21 SARS-CoV2 Omicron Variant: Transmissibility, Clinical Manifestations, Severity and Vaccine Effectiveness
22 SARS-CoV2 Omicron Variant Exponential Transmission and Mitigation Dynamics
23 SARS-CoV2 (COVID-19) Morbidity Implication in Chronic Disease (Type II Diabetes – T2D) and Pancreatic Carcinoma
24 Ukraine Invasion and Global SARS-CoV2 (COVID-19) Pandemic Resurgence: Epigenomic Public Health Perspective
25 SARS-CoV2 (COVID-19) Global Pandemic: \"Extreme Epidemiology\" Response in Transmission and Case Fatality Stabilization, Mitigation and Control
26 Black/African Americans (AA) and Disproportionate Burden of SARS-COV-2 (COVID-19) Mortality in the United States
27 Epidemiologic Risk Modeling of Disproportionate Burden of SARS-CoV2 and COVID-19 Mortality Among Racial/Ethnic Minorities (Social Class) in Washington DC, USA
28 Racial/Ethnic and Geo-Clustering Differentials in SARS-CoV-2 (COVID-19) Cumulative Incidence, Mortality and Temporal Trend in Delaware State, USA
Index